Works matching DE "EPIDERMAL growth factor receptors"

Results: 5000
    1
    2

    Myeloid EGFR deficiency accelerates recovery from AKI via macrophage efferocytosis and neutrophil apoptosis.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-59393-y
    By:
    • Pan, Yu;
    • Cao, Shirong;
    • Wang, Yinqiu;
    • Tang, Jiaqi;
    • Niu, Aolei;
    • Kar, Sarah Abu;
    • Jiang, Mengdi;
    • Peng, Fenfen;
    • Siew, Gabriela M.;
    • Lu, Wentian;
    • Wang, Suwan;
    • Wilson, Matthew;
    • Brooks, Craig;
    • Fogo, Agnes B.;
    • Terker, Andrew S.;
    • Ornelas, Juan Pablo Arroyo;
    • Chen, Jianchun;
    • Zhang, Ming-Zhi;
    • Harris, Raymond C.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 2, p. 443, doi. 10.4143/crt.2024.296
    By:
    • Koh, Jiwon;
    • Kim, Jinyong;
    • Woo, Go-Un;
    • Yi, Hanbaek;
    • Kwon, So Yean;
    • Seo, Jeongmin;
    • Bae, Jeong Mo;
    • Kim, Jung Ho;
    • Won, Jae Kyung;
    • Ryu, Han Suk;
    • Jeon, Yoon Kyung;
    • Lee, Dae-Won;
    • Kim, Miso;
    • Kim, Tae-Yong;
    • Lee, Kyung-Hun;
    • Kim, Tae-You;
    • Lee, Jee-Soo;
    • Seong, Moon-Woo;
    • Kim, Sheehyun;
    • Lee, Sungyoung
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    Ethyl acetate extract of Ruta graveolens : a specific and potent inhibitor against the drug-resistant EGFR_T790M mutant in NSCLC.

    Published in:
    Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1570108
    By:
    • Kumar, Vikas;
    • Chauhan, Leena;
    • Singh, Deepa;
    • Kumar, Akash;
    • Kulandaisamy, Rajkumar;
    • Kushwaha, Tushar;
    • Baswal, Kamal;
    • Singh, Rajan;
    • Kumar, Saroj;
    • Gholap, Shivajirao L.;
    • Hariprasad, P.;
    • Dadinaboyina, S. Babu;
    • Thota, Jagadeshwar R.;
    • Sehgal, Deepak;
    • Appaiahgari, Mohan B.;
    • Inampudi, Krishna K.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29

    Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET‐Guided Verification.

    Published in:
    CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 5, p. 918, doi. 10.1002/psp4.70006
    By:
    • van der Gaag, Suzanne;
    • Jordens, Tamara;
    • Yaqub, Maqsood;
    • Grijseels, Robbin;
    • van Valkengoed, Daan W.;
    • de Langen, Evelien N.;
    • van den Broek, Ruben;
    • Thijssen, Victor L. J. L.;
    • de Langen, Adrianus J.;
    • Kouwenhoven, Mathilde C. M.;
    • Bahce, Idris;
    • Westerman, Bart A.;
    • Hendrikse, N. Harry;
    • Bartelink, Imke H.
    Publication type:
    Article
    30
    31
    32
    33

    E-cadherin mechanotransduction activates EGFR-ERK signaling in epithelial monolayers by inducing ADAM-mediated ligand shedding.

    Published in:
    Science Signaling, 2025, v. 18, n. 886, p. 1, doi. 10.1126/scisignal.adr7926
    By:
    • Houtekamer, Ronja M.;
    • van der Net, Mirjam C.;
    • Vliem, Marjolein J.;
    • Noordzij, Tomas E. J. C.;
    • van Uden, Lisa;
    • van Es, Robert M.;
    • Sim, Joo Yong;
    • Deguchi, Eriko;
    • Terai, Kenta;
    • Hopcroft, Matthew A.;
    • Vos, Harmjan R.;
    • Pruitt, Beth L.;
    • Matsuda, Michiyuki;
    • Pannekoek, Willem-Jan;
    • Gloerich, Martijn
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Epidermal growth factor receptors unveiled: a comprehensive survey on mutations, clinical insights of global inhibitors, and emergence of heterocyclic derivatives as EGFR inhibitors.

    Published in:
    Journal of Drug Targeting, 2025, v. 33, n. 6, p. 933, doi. 10.1080/1061186X.2024.2449495
    By:
    • C, Manojmouli;
    • Pasha, T. Y.;
    • Rahamathulla, Mohamed;
    • H P, Gagana;
    • B L, Kavya;
    • K M, Gagana;
    • K N, Purushotham;
    • Hussain, Shalam M.;
    • Ahmed, Mohammed Muqtader;
    • Shivanandappa, Thippeswamy Boreddy;
    • Pasha, Ismail
    Publication type:
    Article
    43
    44
    45
    46
    47

    Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer.

    Published in:
    Nature Communications, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41467-025-59588-3
    By:
    • Qu, Xueping;
    • Hamidi, Habib;
    • Johnson, Radia M.;
    • Sokol, Ethan S.;
    • Lin, Eva;
    • Eng, Cathy;
    • Kim, Tae Won;
    • Bendell, Johanna;
    • Sivakumar, Smruthy;
    • Kaplan, Benjamin;
    • de Sousa e Melo, Felipe;
    • Mancini, Andrew;
    • Wongchenko, Matthew;
    • Shi, Yi;
    • Shames, David;
    • Yan, Yibing;
    • Ciardiello, Fortunato;
    • Bais, Carlos
    Publication type:
    Article
    48
    49
    50